Rockefeller Capital Management
ZYME icon

Rockefeller Capital Management’s Zymeworks ZYME Stock Holding History

Rockefeller Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53K Buy
+61
New +$1.44K ﹤0.01% 4440
2023
Q1 		– Sell
-1,500
Closed -$11K – 3942
2022
Q4 		$11K Hold
1,500
– – ﹤0.01% 3057
2022
Q3 		$9K Sell
1,500
-1,387
-48% -$8.36K ﹤0.01% 3154
2022
Q2 		$15K Hold
2,887
– – ﹤0.01% 2916
2022
Q1 		$18K Buy
2,887
+1,500
+108% +$13.4K ﹤0.01% 2779
2021
Q4 		$22K Hold
1,387
– – ﹤0.01% 2610
2021
Q3 		$40K Hold
1,387
– – ﹤0.01% 2246
2021
Q2 		$48K Hold
1,387
– – ﹤0.01% 2097
2021
Q1 		$43K Hold
1,387
– – ﹤0.01% 1955
2020
Q4 		$65K Sell
1,387
-501
-27% -$23.3K ﹤0.01% 1598
2020
Q3 		$87K Hold
1,888
– – ﹤0.01% 1316
2020
Q2 		$68K Hold
1,888
– – ﹤0.01% 1322
2020
Q1 		$67K Buy
1,888
+325
+21% +$13.3K ﹤0.01% 1149
2019
Q4 		$71K Sell
1,563
-1,937
-55% -$70.4K ﹤0.01% 1061
2019
Q3 		$87K Buy
+3,500
New +$87.7K ﹤0.01% 832

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Rockefeller Capital Management's ZYME Position: Q1 2026 in Review

Rockefeller Capital Management opened a new position in Zymeworks (ZYME) in Q1 2026: 61 shares worth $1.53K. The stake represents ﹤0.01% of the portfolio and ranks #4440 among its holdings. This is a return to the name: Rockefeller Capital Management previously reported a position in ZYME as recently as Q4 2022.

Rockefeller Capital Management first reported a position in ZYME in Q3 2019 and has held it in 15 quarters since. The position peaked at $87K in Q3 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Rockefeller Capital Management held 61 shares of Zymeworks worth $1.53K as of Q1 2026.
  • Zymeworks was a new Rockefeller Capital Management position in Q1 2026.
  • Zymeworks made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4440 holding.
  • Rockefeller Capital Management first reported a position in Zymeworks in Q3 2019 and has held it in 15 quarters since.
  • Rockefeller Capital Management's Zymeworks position peaked at $87K in Q3 2020.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.